(Q69512743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

title

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

T Leemann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

P Dayer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

U A Meyer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

2 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

739-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3709620%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00615971

2 October 2019

exact match

0 references

cites work

Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation

1 reference

12 December 2020

The genetic controlof bufuralol metabolisminman

1 reference

12 December 2020

Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man

1 reference

12 December 2020

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

1 reference

12 December 2020

Polymorphisms and deficient drug metabolism as triggers of toxic reactions (author's transl)

1 reference

12 December 2020

Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism)--increased Michaelis is Constant (Km) and loss of stereoselectivity of bufuralol 1'-hydroxylation in poor metabolizers

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol

1 reference

12 December 2020

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Quinidine-induced rise in ajmaline plasma concentration

1 reference

12 December 2020

Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme

1 reference

12 December 2020

Defective metabolism of metoprolol in poor hydroxylators of debrisoquine

1 reference

12 December 2020

Oxidation polymorphism has clinical relevance

1 reference

12 December 2020